Abstract:Self-assembly of tau into neurotoxic oligomers and fibrils, and cell-to-cell spreading of these pathological tau species are critical processes underlying the pathogenesis of Alzheimer's disease (AD) and other tauopathies. Modulating the self-assembly process and inhibiting formation and spreading of such toxic species are promising strategies for therapy development. A challenge in investigating tau self-assembly in vitro is that unlike most amyloidogenic proteins, tau does not aggregate in the absence of posttranslational modifications or aggregation inducers. The most common induction method is addition of polyanions, such as heparin, yet this artificial system is not an adequate representation of tau self-assembly in vivo, which is driven by aberrant phosphorylation and other PTMs, potentially leading to in-vitro data that do not represent adequately the behavior of tau and its interaction with modulators in vivo. To tackle these challenges, we compared heparin- induce tau and in-vitro phosphorylated tau aggregation and seeding, and their modulation by a “molecular tweezer”. 2N4R tau was either induced to aggregate by heparin or phosphorylated in-vitro either by ERK2 or by whole rat-brain extract. Aggregation was monitored by thioflavin T fluorescence and electron microscopy. Seeding activity was measured in a FRET-based biosensor cell line. Inhibition of these activities by the molecular tweezer, CLR01, was assessed using the same techniques. Heparin-induced tau behaves differently from in-vitro phosphorylated tau. The aggregation rates of the different forms are distinct as is the intracellular localization of the induced aggregates, which resembles brain-derived tau strains. CLR01 inhibits aggregation and seeding of in-vitro-phosphorylated tau dose-dependently, whereas heparin induction interferes with the interaction between CLR01 and tau. In-vitro phosphorylated tau represents a closer proxy of disease-associated hyperphosphorylated tau than heparin-induced tau and a better system for testing assembly modulators. Using heparin-induced tau aggregation is convenient, but may yield misleading results.

Quantitative Characterization of Heparin Binding to Tau Protein

Glycan Determinants of Heparin-Tau Interaction

Heparin Remodels the Microtubule-Binding Repeat R3 of Tau Protein Towards Fibril-Prone Conformations

Cooperative Folding of Tau Peptide by Coordination of Group IIB Metal Cations During Heparin-Induced Aggregation

F2-06-01: MAJOR DIFFERENCES BETWEEN THE SELF-ASSEMBLY, SEEDING BEHAVIOR, AND INTERACTION WITH MODULATORS OF HEPARIN-INDUCED VERSUS IN-VITRO PHOSPHORYLATED TAU

Unraveling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Unravelling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Fibrillization Of Human Tau Is Accelerated By Exposure To Lead Via Interaction With His-330 And His-362

Nanoscale observation of heparin-mediated self-assembly of chiral tau enantiomers

Under Heparin-Free Conditions Unsaturated Phospholipids Inhibit the Aggregation of 1N4R and 2N4R Tau

Proline-Rich Region II (PRR2) Plays an Important Role in Tau–Glycan Interaction: an NMR Study

Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry

Effect of Alcohol on Aggregation of Human Neuronal Tau Protein

Alzheimer disease hyperphosphorylated tau aggregates hydrophobically

Tau (297‐391) Forms Filaments That Structurally Mimic the Core of Paired Helical Filaments in Alzheimer’s Disease Brain

Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology

Initiation and modulation of Tau protein phase separation by the drug suramin

The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology

Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation

Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Alzheimer's Disease Seeded Tau Forms Paired Helical Filaments Yet Lacks Seeding Potential